Cargando…

The internal dosimetry user group position statement on molecular radiotherapy

The Internal Dosimetry User Group (IDUG) is an independent, non-profit group of medical professionals dedicated to the promotion of dosimetry in molecular radiotherapy (www.IDUG.org.uk). The Ionising Radiation (Medical Exposure) Regulations 2017, IR(ME)R, stipulate a requirement for optimisation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gear, Jonathan, McGowan, Daniel, Rojas, Bruno, Craig, Allison J, Smith, April-Louise, Scott, Catherine J, Scuffam, James, Aldridge, Matthew, Tipping, Jill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Institute of Radiology. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328072/
https://www.ncbi.nlm.nih.gov/pubmed/34433005
http://dx.doi.org/10.1259/bjr.20210547
_version_ 1784757632608763904
author Gear, Jonathan
McGowan, Daniel
Rojas, Bruno
Craig, Allison J
Smith, April-Louise
Scott, Catherine J
Scuffam, James
Aldridge, Matthew
Tipping, Jill
author_facet Gear, Jonathan
McGowan, Daniel
Rojas, Bruno
Craig, Allison J
Smith, April-Louise
Scott, Catherine J
Scuffam, James
Aldridge, Matthew
Tipping, Jill
author_sort Gear, Jonathan
collection PubMed
description The Internal Dosimetry User Group (IDUG) is an independent, non-profit group of medical professionals dedicated to the promotion of dosimetry in molecular radiotherapy (www.IDUG.org.uk). The Ionising Radiation (Medical Exposure) Regulations 2017, IR(ME)R, stipulate a requirement for optimisation and verification of molecular radiotherapy treatments, ensuring doses to non-target organs are as low as reasonably practicable. For many molecular radiotherapy treatments currently undertaken within the UK, this requirement is not being fully met. The growth of this field is such that we risk digressing further from IR(ME)R compliance potentially delivering suboptimal therapies that are not in the best interest of our patients. For this purpose, IDUG proposes ten points of action to aid in the successful implementation of this legislation. We urge stakeholders to support these proposals and ensure national provision is sufficient to meet the criteria necessary for compliance, and for the future advancement of molecular radiotherapy within the UK.
format Online
Article
Text
id pubmed-9328072
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The British Institute of Radiology.
record_format MEDLINE/PubMed
spelling pubmed-93280722022-08-05 The internal dosimetry user group position statement on molecular radiotherapy Gear, Jonathan McGowan, Daniel Rojas, Bruno Craig, Allison J Smith, April-Louise Scott, Catherine J Scuffam, James Aldridge, Matthew Tipping, Jill Br J Radiol Guidelines & Recommendations The Internal Dosimetry User Group (IDUG) is an independent, non-profit group of medical professionals dedicated to the promotion of dosimetry in molecular radiotherapy (www.IDUG.org.uk). The Ionising Radiation (Medical Exposure) Regulations 2017, IR(ME)R, stipulate a requirement for optimisation and verification of molecular radiotherapy treatments, ensuring doses to non-target organs are as low as reasonably practicable. For many molecular radiotherapy treatments currently undertaken within the UK, this requirement is not being fully met. The growth of this field is such that we risk digressing further from IR(ME)R compliance potentially delivering suboptimal therapies that are not in the best interest of our patients. For this purpose, IDUG proposes ten points of action to aid in the successful implementation of this legislation. We urge stakeholders to support these proposals and ensure national provision is sufficient to meet the criteria necessary for compliance, and for the future advancement of molecular radiotherapy within the UK. The British Institute of Radiology. 2021-10-01 2022-07-08 /pmc/articles/PMC9328072/ /pubmed/34433005 http://dx.doi.org/10.1259/bjr.20210547 Text en © 2021 The Authors. Published by the British Institute of Radiology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Unported License http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial reuse, provided the original author and source are credited.
spellingShingle Guidelines & Recommendations
Gear, Jonathan
McGowan, Daniel
Rojas, Bruno
Craig, Allison J
Smith, April-Louise
Scott, Catherine J
Scuffam, James
Aldridge, Matthew
Tipping, Jill
The internal dosimetry user group position statement on molecular radiotherapy
title The internal dosimetry user group position statement on molecular radiotherapy
title_full The internal dosimetry user group position statement on molecular radiotherapy
title_fullStr The internal dosimetry user group position statement on molecular radiotherapy
title_full_unstemmed The internal dosimetry user group position statement on molecular radiotherapy
title_short The internal dosimetry user group position statement on molecular radiotherapy
title_sort internal dosimetry user group position statement on molecular radiotherapy
topic Guidelines & Recommendations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328072/
https://www.ncbi.nlm.nih.gov/pubmed/34433005
http://dx.doi.org/10.1259/bjr.20210547
work_keys_str_mv AT gearjonathan theinternaldosimetryusergrouppositionstatementonmolecularradiotherapy
AT mcgowandaniel theinternaldosimetryusergrouppositionstatementonmolecularradiotherapy
AT rojasbruno theinternaldosimetryusergrouppositionstatementonmolecularradiotherapy
AT craigallisonj theinternaldosimetryusergrouppositionstatementonmolecularradiotherapy
AT smithaprillouise theinternaldosimetryusergrouppositionstatementonmolecularradiotherapy
AT scottcatherinej theinternaldosimetryusergrouppositionstatementonmolecularradiotherapy
AT scuffamjames theinternaldosimetryusergrouppositionstatementonmolecularradiotherapy
AT aldridgematthew theinternaldosimetryusergrouppositionstatementonmolecularradiotherapy
AT tippingjill theinternaldosimetryusergrouppositionstatementonmolecularradiotherapy
AT gearjonathan internaldosimetryusergrouppositionstatementonmolecularradiotherapy
AT mcgowandaniel internaldosimetryusergrouppositionstatementonmolecularradiotherapy
AT rojasbruno internaldosimetryusergrouppositionstatementonmolecularradiotherapy
AT craigallisonj internaldosimetryusergrouppositionstatementonmolecularradiotherapy
AT smithaprillouise internaldosimetryusergrouppositionstatementonmolecularradiotherapy
AT scottcatherinej internaldosimetryusergrouppositionstatementonmolecularradiotherapy
AT scuffamjames internaldosimetryusergrouppositionstatementonmolecularradiotherapy
AT aldridgematthew internaldosimetryusergrouppositionstatementonmolecularradiotherapy
AT tippingjill internaldosimetryusergrouppositionstatementonmolecularradiotherapy